1. Skip to navigation
  2. Skip to content

Biomedical Polymers and Compounds™

Press Releases

Foster Offers Non-Migratory Antistatic Polymers for Medical Applications

PUTNAM, CT, USA  - (October 29, 2013) -  Foster Corporation, a leader in custom polymers for medical devices, introduces static dissipative polymer blends specifically designed for medical devices and equipment. These blends use a non-migratory, polyether block amide (PEBA) polymer additive that retains continuous antistatic properties and cannot be wiped off with medical cleaning agents.  

Foster ProPell™ Compounds Improve Catheter Manufacturing in Low Durometer Polymers

PUTNAM, CT, USA - (June 18, 2013) - Foster Corporation, a leader in custom polymers for medical devices, introduces ProPell™ thermoplastic polyurethane (TPU) and polyether block amide (PEBA) compounds for improved manufacturing and handling of medical catheters.  These new compounds dramatically reduce tackiness and friction in soft, flexible polymers while maintaining other physical properties of the unmodified polymers. 

Foster Expands Nano-Reinforced Polymer Range for Medical Devices

PUTNAM, CT, USA - (April 2, 2013) - Foster Corporation, a leader in custom polymer compounds for medical devices, now offers nano-reinforced composites for minimally invasive devices, such as catheters, with reinforcement loadings up to 30% by weight.  Nano-reinforced compounds with high filler loadings provide substantial increase in physical properties of the base resin while maintaining processibility in thin wall components.

Foster Expands Global Engineering Support to Asia Pacific

PUTNAM, CT, USA - (December 13, 2012) -  Foster Corporation, a leader in custom polymer formulations for medical device and drug delivery applications, now offers regional technical service and product development support in Asia Pacific.  Amar Nilajkar, a ten year veteran of the company, will support medical device and pharmaceutical customers in the region from a newly established office in India. 

Foster Recognized in Deloitte's Technology Fast 500™

PUTNAM, CT - (November 14, 2012) - Foster Corporation today announced it ranked in Deloitte’s Technology Fast 500™, a ranking of the 500 fastest growing technology, media, telecommunications, life sciences and clean technology companies in North America.  Foster Corporation grew 149% percent from 2007 to 2011.

Foster Reports Increased Interest in Implantable Applications by Polymer Suppliers

Putnam, CT, USA - (October 16, 2012) -  Foster Corporation, a leader in custom medical polymers, reports increased interest in implantable medical device applications by polymer suppliers.  While risk mitigation remains a primary concern, increased acceptance and application of polymers by device manufacturers for temporary and permanent implants presents opportunities for growth for performance polymers.

Foster Corporation Awarded Connecticut Technology Council 2012 Marcum Tech Top 40 Winner

Putnam, CT, USA --  (August 6, 2012) -- Foster Corporation, a leader in custom medical polymers, has been recognized as one of Connecticut's 40 fastest growing technology companies in 2012 by the Connecticut Technology Council (CTC) and Marcum LLP. This marks the 9th time in the past 15 years that Foster has been recognized as one of the fastest growing technology companies by CTC and Marcum LLP.

Foster Delivery Science Offers Custom Radiopaque PEEK Compounds for Orthopedic Implants

PUTNAM, CT, USA – (June 11, 2012) – Foster Delivery Science, a business unit of Foster Corporation that specializes in contract development and manufacturing of implant and drug delivery polymers, now offers custom radiopaque PEEK compounds for use in long term orthopedic implants. A twin screw extruder within the company’s Class 7 cGMP clean room is designed to produce development PEEK compound batches as small at 5 lbs (2.27 kg) through production quantities.

Foster Corportion Explans Manufacturing Capabilities for Custom Pre-Color Polymers

PUTNAM, CT, USA – (May 22, 2012) – Foster Corporation, a leader in custom medical polymers, has added state-of-the-art extrusion compounding capacity for custom pre-colored polymers used in Class I medical applications. The new line is designed to optimize pigment dispersion of challenging colors and polymers, and maximize throughput necessary to reduce compounding costs.

Arkema Inc. Extends Notification for Change to Medical Grade Pebax® Polymers

King of Prussia, PA -- Arkema Inc. has implemented a 12-month advance notice for product specification changes on all Pebax® SA 01 MED polymers in order to provide medical device manufacturers with the necessary time for regulatory assessment.  Previously, notifications of change for these polymers sold in the medical market were unrestricted, similar to grades sold in non-medical markets.

  1. Skip to navigation
  2. Skip to content
  3. Back to top